Icenticaftor (QBW251)
Selleck Chemicals
SKU:S9972-1MG
Couldn't load pickup availability

Icenticaftor (QBW251) is a research compound associated with CFTR and is relevant to studies of ion-channel pharmacology. It is especially relevant in cell signaling and endocrinology models, where defined compound exposure can be linked to ion conductance, membrane potential, and electrophysiological responses.
The current annotation links Icenticaftor (QBW251) to CFTR, supporting target-focused studies that measure ion conductance, membrane potential, and electrophysiological responses without assigning a more specific primary mechanism than the dataset provides. This target class is commonly examined through electrophysiology, ion-flux, and membrane-potential studies, together with downstream-response mapping. In cell signaling and endocrinology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving CFTR
- Electrophysiology, ion-flux, and membrane-potential studies
- Phenotypic profiling in cell signaling and endocrinology models
- Combination studies with orthogonal perturbagens
Overall, Icenticaftor (QBW251) is appropriate when a defined chemical perturbant is needed to connect CFTR with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cell signaling and endocrinology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- CFTR
- Target Class:
- Ion Channel
- Research Area:
- Cell Signaling • Endocrinology
- CAS No.:
- 1334546-77-8
- Molecular Weight:
- 361.24
- Formula:
- C₁₂H₁₃F₆N₃O₃
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.